Ask AI
ProCE Banner Activity

Mastering the Evolving Treatment Paradigm in SCLC: Immunotherapy Transforming Care for LS-SCLC

Slideset

Download these slides to gain expert insight into the current treatment paradigm and incorporating immunotherapy into personalized treatment plans for patients with limited-stage small-cell lung cancer.

Released: May 30, 2025

Expiration: November 29, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Amgen, Daiichi Sankyo, Inc., Jazz Pharmaceuticals, Inc. and Merck Sharp & Dohme LLC.

Amgen

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals, Inc.

Merck Sharp & Dohme, LLC